Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Ciprofloxacin-d8 is intended for use as an internal standard for the quantification of... more
Product information "Ciprofloxacin-d8 (hydrochloride)"
Ciprofloxacin-d8 is intended for use as an internal standard for the quantification of ciprofloxacin (Cay-14286) by GC- or LC-MS. Ciprofloxacin is a fluoroquinolone antibiotic. It is active against a variety of Gram-positive and Gram-negative bacteria in vitro, including S. aureus, L. monocytogenes, P. aeruginosa, Legionella, N. gonorrhoeae, and H. pylori (MIC50s = 0.004-1 µg/ml). It is also active against clinical isolates of Bacteroides, Fusobacterium, Eubacterium, Actinomyces, Peptococcus, Peptostreptococcus, and Streptococcus in vitro (MIC50s = 0.5-2 µg/ml). Ciprofloxacin inhibits S. aureus DNA gyrase and topoisomerase IV (IC50s = 13.5 and 5.76 µg/ml, respectively). It reduces mortality in mouse models of intraperitoneal E. coli, P. vulgaris, K. pneumoniae, P. aeruginosa, and S. aureus infection (ED90-100s = 1-5, 2.5-5, 5-10, 20-40, and 80 mg/kg, respectively) and prevents mortality in a mouse model of subcutaneous S. typhimurium infection at 10 mg/kg. Formulations containing ciprofloxacin have been used in the treatment of bacterial infections.Formal Name: 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-1,4-dihydroquinoline-3-carboxylic acid, monohydrochloride. CAS Number: 1216659-54-9. Molecular Formula: C17H10D8FN3O3 . HCl. Formula Weight: 375.9. Purity: >99% deuterated forms (d1-d8). Formulation: (Request formulation change), A solid. Solubility: Methanol: Slightly Soluble, Water: Slightly Soluble. SMILES: FC1=CC2=C(C=C1N3C([2H])([2H])C([2H])([2H])NC([2H])([2H])C3([2H])[2H])N(C4CC4)C=C(C(O)=O)C2=O.Cl. InChi Code: InChI=1S/C17H18FN3O3.ClH/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24,/h7-10,19H,1-6H2,(H,23,24),1H/i3D2,4D2,5D2,6D2,. InChi Key: DIOIOSKKIYDRIQ-JCYLEXHWSA-N.
Keywords: | 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-1,4-dihydroquinoline-3-carboxylic acid, monohydrochloride |
Supplier: | Cayman Chemical |
Supplier-Nr: | 25466 |
Properties
Application: | Antibiotic, GC-MS, LC-MS, Internal standard |
MW: | 375.9 D |
Formula: | C17H10D8FN3O3 . HCl |
Purity: | >99% deuterated forms (d1-d8) |
Format: | Solid |
Database Information
CAS : | 1216659-54-9| Matching products |
KEGG ID : | K02469 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: -20°C) |
Signal Word: | Warning |
GHS Hazard Pictograms: |
|
H Phrases: | H319, H400, H410 |
P Phrases: | P264, P273, P280, P305+351+338, P337+313, P391, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed